Annovis Bio
(NYSE) ANVS
Annovis Bio Financials at a Glance
Market Cap
$75.71M
Revenue (TTM)
$0.00
Net Income (TTM)
$28.85M
EPS (TTM)
$-1.40
P/E Ratio
-1.90
Dividend
$0.00
Beta (Volatility)
1.46 (Average)
Dividend
$0.00
Beta (Volatility)
1.46 (Average)
Price
$2.52
Volume
422,804.398
Open
$2.64
Price
$2.52
Volume
422,804.398
Open
$2.64
Previous Close
$2.67
Daily Range
$2.51 - $2.72
52-Week Range
$1.11 - $5.50
Dividend
$0.00
Beta (Volatility)
1.46 (Average)
Price
$2.52
Volume
422,804.398
Open
$2.64
Previous Close
$2.67
Daily Range
$2.51 - $2.72
52-Week Range
$1.11 - $5.50
ANVS News
ANVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Annovis Bio
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Maria-Luisa Maccecchini, PhD
Website
www.annovisbio.comHeadquarters
Malvern, PA 19312, US
ANVS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-221%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
-52.63%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$75.71M
Shares Outstanding
28.36M
Volume
422.80K
Short Interest
0.00%
Avg. Volume
427.15K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$29.70M
EBITDA
$29.70M
Operating Cash Flow
$25.62B
Capital Expenditure
$0.00
Free Cash Flow
$25.62B
Cash & ST Invst.
$19.53B
Total Debt
$0.00
Annovis Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$75.71M
N/A
Market Cap/Employee
$9.46M
N/A
Employees
8
N/A
Net Income
$9.83M
-67.7%
EBITDA
$9.71M
-44.1%
Quarterly Fundamentals
Net Cash
$19.53B
+185007.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-0.14%
N/A
Return on Invested Capital
-0.17%
N/A
Free Cash Flow
$835.97M
-9989.7%
Operating Cash Flow
$835.97M
-9989.7%